• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆酸/脂肪酸整合纳米乳囊用于非酒精性脂肪肝靶向洛伐他汀传递:稳定性、 和 分析。

Bile acid/fatty acid integrated nanoemulsomes for nonalcoholic fatty liver targeted lovastatin delivery: stability, , and analyses.

机构信息

Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Faisalabad, Pakistan.

Ocular Therapeutics Research Group, Pharmaceutical and Molecular Biotechnology Research Centre, Department of Science, Waterford Campus, South East Technological University (SETU), Waterford, Ireland.

出版信息

Expert Opin Drug Deliv. 2024 May;21(5):779-796. doi: 10.1080/17425247.2024.2361117. Epub 2024 May 31.

DOI:10.1080/17425247.2024.2361117
PMID:38795359
Abstract

BACKGROUND

Controlled and targeted drug delivery to treat nonalcoholic fatty liver disease (NAFLD) can benefit from additive attributes of natural formulation ingredients incorporated into the drug delivery vehicles.

METHODS

Lovastatin (LVN) loaded, bile acid (BA) and fatty acid (FA) integrated nanoemulsomes (NES) were formulated by thin layer hydration technique for synergistic and targeted delivery of LVN to treat NAFLD. Organic phase NES was comprised of stearic acid with garlic (GL) and ginger (GR) oils, separately. Ursodeoxycholic acid and linoleic acid were individually incorporated as targeting moieties.

RESULTS

Stability studies over 90 days showed average NES particle size, surface charge, polydispersity index, and entrapment efficiency values of 270 ± 27.4 nm, -23.8 ± 3.5 mV, 0.2 ± 0.04 and 81.36 ± 3.4%, respectively. Spherical NES were observed under a transmission electron microscope. LVN release depicted non-fickian release mechanisms from GL and GR oils-based NES. permeation of BA/FA integrated NES through isolated rat intestines showed greater flux than non-integrated ones.

CONCLUSION

Liver histopathology of experimental rats together with in-vivo lipid profiles and liver function tests illustrated that these NES possess the clinical potential to be promising drug carriers for NAFLD.

摘要

背景

控制和靶向药物输送治疗非酒精性脂肪性肝病(NAFLD)可以受益于天然配方成分的附加属性,这些属性被整合到药物输送载体中。

方法

通过薄层水化技术制备载洛伐他汀(LVN)、胆酸(BA)和脂肪酸(FA)整合的纳米乳囊(NES),以协同和靶向输送 LVN 来治疗 NAFLD。有机相 NES 由硬脂酸与大蒜(GL)和姜(GR)油组成,分别。熊去氧胆酸和亚油酸分别作为靶向部分被整合。

结果

90 天的稳定性研究显示,平均 NES 粒径、表面电荷、多分散指数和包封效率值分别为 270±27.4nm、-23.8±3.5mV、0.2±0.04 和 81.36±3.4%。在透射电子显微镜下观察到球形 NES。GL 和 GR 油基 NES 中的 LVN 释放呈现非菲克扩散机制。BA/FA 整合的 NES 通过分离的大鼠肠的渗透显示出比非整合的 NES 更高的通量。

结论

实验大鼠的肝脏组织病理学以及体内脂质谱和肝功能测试表明,这些 NES 具有成为治疗 NAFLD 的有前途的药物载体的临床潜力。

相似文献

1
Bile acid/fatty acid integrated nanoemulsomes for nonalcoholic fatty liver targeted lovastatin delivery: stability, , and analyses.胆酸/脂肪酸整合纳米乳囊用于非酒精性脂肪肝靶向洛伐他汀传递:稳定性、 和 分析。
Expert Opin Drug Deliv. 2024 May;21(5):779-796. doi: 10.1080/17425247.2024.2361117. Epub 2024 May 31.
2
Hepatoprotective and Renoprotective Properties of Lovastatin-Loaded Ginger and Garlic Oil Nanoemulsomes: Insights into Serum Biological Parameters.洛伐他汀姜蒜油纳米乳囊的肝保护和肾保护特性:对血清生物学参数的深入了解。
Medicina (Kaunas). 2019 Sep 9;55(9):579. doi: 10.3390/medicina55090579.
3
Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics.亲脂性乳化剂对纳米结构脂质载体中洛伐他汀口服给药的影响:理化特性和药代动力学。
Eur J Pharm Biopharm. 2010 Mar;74(3):474-82. doi: 10.1016/j.ejpb.2009.12.008. Epub 2010 Jan 7.
4
Development of lovastatin-loaded poly(lactic acid) microspheres for sustained oral delivery: in vitro and ex vivo evaluation.用于口服持续给药的载洛伐他汀聚乳酸微球的研制:体外和离体评价
Drug Des Devel Ther. 2015 Feb 10;9:791-8. doi: 10.2147/DDDT.S76676. eCollection 2015.
5
Preparation, characterization, and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticles.洛伐他汀固体脂质纳米粒的制备、表征及体外和体内评价
AAPS PharmSciTech. 2007 Mar 23;8(1):24. doi: 10.1208/pt0801024.
6
Improvement of oral bioavailability of lovastatin by using nanostructured lipid carriers.使用纳米结构脂质载体提高洛伐他汀的口服生物利用度。
Drug Des Devel Ther. 2015 Sep 18;9:5269-75. doi: 10.2147/DDDT.S90016. eCollection 2015.
7
Formulation design, characterization, and in vitro and in vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of gypenosides.载有胆汁盐的纳米结构脂质载体的制剂设计、特性分析,及其口服递送绞股蓝皂苷的体内外评价。
Int J Nanomedicine. 2019 Apr 1;14:2267-2280. doi: 10.2147/IJN.S194934. eCollection 2019.
8
QbD-based systematic development of novel optimized solid self-nanoemulsifying drug delivery systems (SNEDDS) of lovastatin with enhanced biopharmaceutical performance.基于 QbD 的新型优化洛伐他汀固体自微乳给药系统(SNEDDS)的系统开发,具有增强的生物药剂学性能。
Drug Deliv. 2015;22(6):765-84. doi: 10.3109/10717544.2014.900154. Epub 2014 Mar 27.
9
Development and Characterization of Saturated Fatty Acid-Engineered, Silica-Coated Lipid Vesicular System for Effective Oral Delivery of Alfa-Choriogonadotropin.基于饱和脂肪酸工程和硅涂层脂质泡囊系统的阿法绒毛膜促性腺激素有效口服递释系统的构建与评价
AAPS PharmSciTech. 2021 Mar 29;22(3):118. doi: 10.1208/s12249-021-01985-0.
10
Design, Synthesis, and Characterization of Folate-Targeted Platinum-Loaded Theranostic Nanoemulsions for Therapy and Imaging of Ovarian Cancer.用于卵巢癌治疗与成像的叶酸靶向载铂诊疗纳米乳剂的设计、合成与表征
Mol Pharm. 2016 Jun 6;13(6):1996-2009. doi: 10.1021/acs.molpharmaceut.6b00149. Epub 2016 May 24.

引用本文的文献

1
Therapeutic Nanomaterials in NAFLD: Current Advances and Potential Applications in Patients with Concurrent HBV Infection.非酒精性脂肪性肝病中的治疗性纳米材料:在合并乙型肝炎病毒感染患者中的当前进展及潜在应用
Int J Nanomedicine. 2025 Mar 25;20:3803-3823. doi: 10.2147/IJN.S510271. eCollection 2025.